3. — Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16…

3.

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

The application shall be signed by the sponsor or a representative of the sponsor. This signature confirms that the sponsor is satisfied that: the information provided is complete; the attached documents contain an accurate account of the information available; the clinical trial is to be conducted in accordance with the protocol; and the clinical trial is to be conducted in accordance with this Regulation.

← anx_I__cpt_1__point_2__text_1 · All articles · anx_I__cpt_1__point_3__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.